![](/img/cover-not-exists.png)
Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2âP3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach
Achilonu, Ikechukwu, Iwuchukwu, Emmanuel Amarachi, Achilonu, Okechinyere Juliet, Fernandes, Manuel Antonio, Sayed, YasienVolume:
101
Journal:
Journal of Molecular Graphics and Modelling
DOI:
10.1016/j.jmgm.2020.107730
Date:
December, 2020
File:
PDF, 3.49 MB
2020